Furthermore, GGT5 displayed positive enrichment in three pathways, including cytokine cytokine receptor interaction, complement and coagulation cascades, and hematopoietic cell lineage, and negative enrichment in two pathways, including oxidative phosphorylation and Parkinsons disease (Figure 6C). This evidence concerns the gene GGT5 and Parkinson disease.